DBVT Q2 2019 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-0.5% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$45M-1328.1% margin

Net Income

-$45M-1336.2% margin

EPS (Diluted)

$-6.90

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$241M

Total Liabilities

$91M

Stockholders' Equity

$150M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-0.5%
Gross Profit	$3M	$3M	-0.5%
Operating Income	-$45M	-$43M	-5.1%
Net Income	-$45M	-$42M	-7.8%